A detailed history of Strategy Asset Managers LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Strategy Asset Managers LLC holds 36,005 shares of MRK stock, worth $3.53 Million. This represents 0.79% of its overall portfolio holdings.

Number of Shares
36,005
Previous 48,058 25.08%
Holding current value
$3.53 Million
Previous $5.95 Million 31.28%
% of portfolio
0.79%
Previous 1.18%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$111.15 - $128.97 $1.34 Million - $1.55 Million
-12,053 Reduced 25.08%
36,005 $4.09 Million
Q2 2024

Aug 02, 2024

BUY
$123.8 - $132.96 $1.48 Million - $1.59 Million
11,957 Added 33.12%
48,058 $5.95 Million
Q1 2024

Apr 25, 2024

SELL
$113.24 - $131.95 $546,949 - $637,318
-4,830 Reduced 11.8%
36,101 $4.76 Million
Q4 2023

Feb 12, 2024

SELL
$100.18 - $109.02 $89,861 - $97,790
-897 Reduced 2.14%
40,931 $4.46 Million
Q3 2023

Nov 09, 2023

SELL
$102.95 - $114.33 $641,378 - $712,275
-6,230 Reduced 12.96%
41,828 $4.31 Million
Q2 2023

Aug 24, 2023

BUY
$108.61 - $118.38 $576,176 - $628,005
5,305 Added 12.41%
48,058 $5.55 Million
Q1 2023

May 02, 2023

BUY
$102.94 - $114.86 $388,701 - $433,711
3,776 Added 9.69%
42,753 $4.55 Million
Q4 2022

Jan 13, 2023

SELL
$87.44 - $112.11 $19,236 - $24,664
-220 Reduced 0.56%
38,977 $4.33 Million
Q3 2022

Oct 11, 2022

BUY
$84.53 - $94.96 $693,906 - $779,526
8,209 Added 26.49%
39,197 $3.38 Million
Q2 2022

Jul 13, 2022

BUY
$83.49 - $94.64 $56,188 - $63,692
673 Added 2.22%
30,988 $2.83 Million
Q1 2022

Apr 11, 2022

BUY
$73.51 - $82.4 $217,663 - $243,986
2,961 Added 10.82%
30,315 $2.49 Million
Q4 2021

Jan 14, 2022

SELL
$72.28 - $90.54 $227,465 - $284,929
-3,147 Reduced 10.32%
27,354 $2.1 Million
Q3 2021

Dec 14, 2021

SELL
$71.68 - $78.83 $33,331 - $36,655
-465 Reduced 1.5%
30,501 $2.29 Million
Q2 2021

Aug 04, 2021

SELL
$70.31 - $77.77 $5.81 Million - $6.43 Million
-82,660 Reduced 72.75%
30,966 $2.41 Million
Q1 2021

May 12, 2021

SELL
$68.86 - $81.11 $242,731 - $285,912
-3,525 Reduced 3.01%
113,626 $8.76 Million
Q4 2020

Feb 10, 2021

SELL
$71.77 - $79.65 $318,587 - $353,566
-4,439 Reduced 3.65%
117,151 $9.58 Million
Q3 2020

Nov 03, 2020

SELL
$73.18 - $82.95 $1.06 Million - $1.2 Million
-14,424 Reduced 10.6%
121,590 $10.1 Million
Q2 2020

Aug 10, 2020

SELL
$70.42 - $80.13 $262,032 - $298,163
-3,721 Reduced 2.66%
136,014 $10.5 Million
Q1 2020

May 14, 2020

SELL
$63.36 - $87.82 $613,895 - $850,887
-9,689 Reduced 6.48%
139,735 $10.8 Million
Q4 2019

Feb 13, 2020

SELL
$77.58 - $87.54 $134,213 - $151,444
-1,730 Reduced 1.14%
149,424 $13.6 Million
Q3 2019

Nov 13, 2019

BUY
$76.08 - $82.93 $227,783 - $248,292
2,994 Added 2.02%
151,154 $12.7 Million
Q2 2019

Aug 14, 2019

BUY
$69.84 - $81.59 $11,104 - $12,972
159 Added 0.11%
148,160 $12.4 Million
Q1 2019

May 08, 2019

BUY
$69.58 - $79.36 $519,414 - $592,422
7,465 Added 5.31%
148,001 $12.3 Million
Q4 2018

Feb 14, 2019

SELL
$65.24 - $75.71 $482,319 - $559,724
-7,393 Reduced 5.0%
140,536 $10.7 Million
Q3 2018

Nov 01, 2018

SELL
$57.69 - $67.84 $156,974 - $184,592
-2,721 Reduced 1.81%
147,929 $0
Q2 2018

Aug 07, 2018

SELL
$50.83 - $59.72 $139,325 - $163,692
-2,741 Reduced 1.79%
150,650 $9.14 Million
Q1 2018

May 03, 2018

SELL
$50.96 - $59.23 $196,960 - $228,923
-3,865 Reduced 2.46%
153,391 $8.36 Million
Q4 2017

Jan 29, 2018

BUY
$51.62 - $61.64 $48,884 - $58,373
947 Added 0.61%
157,256 $8.85 Million
Q3 2017

Nov 06, 2017

SELL
$58.67 - $63.13 $131,596 - $141,600
-2,243 Reduced 1.41%
156,309 $10 Million
Q2 2017

Aug 07, 2017

BUY
N/A
158,552
158,552 $10.2 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Strategy Asset Managers LLC Portfolio

Follow Strategy Asset Managers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategy Asset Managers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategy Asset Managers LLC with notifications on news.